{"product_id":"gw0742-sarm","title":"GW0742 | 50mg\/1,5ml","description":"\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eWhat is GW0742?\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eGW0742 is a synthetic peroxisome proliferator-activated receptor delta (PPAR-δ) agonist investigated as a potential regulator of metabolic and energy processes. Structurally related to GW501516, GW0742 exhibits higher selectivity and affinity for PPAR-δ, making it a valuable research target targeting the regulation of lipid and glucose metabolism, energy balance, and muscle oxidation. Due to its specific activity, the compound is used in a laboratory environment to analyze molecular mechanisms related to mitochondrial function, metabolic flexibility and physical endurance.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eGW0742 Mechanism of Action:\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eGW0742 binds selectively to PPAR-δ receptors – nuclear receptors involved in the regulation of the expression of genes related to energy metabolism. Activation of these receptors leads to stimulation of fatty acid oxidation, improvement of mitochondrial activity and increase of energy efficiency in muscle tissue. Furthermore, GW0742 modulates glucose homeostasis and affects the lipid profile without directly affecting the hormonal axis. It is this mechanism that makes it particularly interesting in scientific research focused on metabolic diseases, endurance training and energy adaptation.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003ePotential scientifically supported benefits of GW0742:\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eGW0742 has been the subject of a number of analyzes in which the following potential effects have been observed:\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan\u003eIncreased fat burning by stimulating β-oxidation;\u003c\/span\u003e\u003c\/li\u003e\n\u003cli dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan\u003eIncreased mitochondrial activity and energy efficiency in muscles;\u003c\/span\u003e\u003c\/li\u003e\n\u003cli dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan\u003eImproved glucose sensitivity and glycemic control;\u003c\/span\u003e\u003c\/li\u003e\n\u003cli dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan\u003ePotentially supporting physical endurance;\u003c\/span\u003e\u003c\/li\u003e\n\u003cli dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan\u003eAnti-inflammatory modulation through regulation of PPAR-δ dependent pathways;\u003c\/span\u003e\u003c\/li\u003e\n\u003cli dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan\u003eMaintaining a healthy lipid profile.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eDue to these observations, GW0742 is frequently included in protocols for the study of metabolic disorders, sports physiology and cardiometabolic mechanisms.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eComparison of GW0742 with other SARMs and metabolic agonists\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eGW0742 is a synthetic PPAR-δ (peroxisome proliferator-activated receptor delta) agonist that is not a SARM, but is often grouped with them due to its similar use in metabolic regulation, lipid control, and endurance research protocols. It is most commonly compared to Cardarine (GW501516), Stenabolic (SR9009) and sometimes to lighter SARMs such as Ostarine (MK2866) when combined for body recomposition purposes.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eCompared to Cardarine, GW0742 has a higher affinity for the PPAR-δ receptor, making it more potent in models investigating fat oxidation and improvement of mitochondrial function. Both molecules promote the use of fat as a primary energy source, but GW0742 is often preferred in more targeted metabolic studies, especially when a more selective effect on energy metabolism in muscle tissue is sought.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eCompared to Stenabolic (SR9009), which acts by activating REV-ERBα and affecting circadian rhythms, GW0742 is more focused on the deep regulation of lipid metabolism and glucose homeostasis, without directly affecting the biological clock. While SR9009 improves energy capacity and endurance through mitochondrial activity, GW0742 does so by activating metabolic genes responsible for fatty acid oxidation.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eIn the context of SARMs such as Ostarine or Ligandrol, which affect muscle mass through androgen receptors, GW0742 stands out as a completely non-hormonal metabolic modulator suitable for studies where the goal is fat burning, improved insulin sensitivity and metabolic flexibility.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDosage and administration of GW0742 in research protocols:\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eRecommended study schedule: 5-6 units once daily for 4-6 weeks, followed by a 2-4 week rest period.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e1 unit = \u003cmeta charset=\"utf-8\"\u003e\n\u003cspan data-sheets-root=\"1\"\u003e333mcg\u003c\/span\u003e.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eTotal quantity in pen: 150 units\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003ePossible side effects of GW0742:\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eWhile GW0742 shows promising results, it is important to consider its safety profile. Its observed negative effects include:\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan\u003eChanges in lipid metabolism during long-term use;\u003c\/span\u003e\u003c\/li\u003e\n\u003cli dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan\u003eLack of long-term data on chronic exposure;\u003c\/span\u003e\u003c\/li\u003e\n\u003cli dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan\u003eAdverse interactions with other PPAR-modulating compounds.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eAdherence to the optimal dosage and control of the duration of application play a key role in limiting the occurrence of side effects.\u003c\/span\u003e\u003c\/p\u003e","brand":"Pen Peptide","offers":[{"title":"Default Title","offer_id":53031827931403,"sku":"1234","price":95.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0696\/8737\/8187\/files\/gw0742-sarm.jpg?v=1775584561","url":"https:\/\/dtspharmacy.com\/products\/gw0742-sarm","provider":"PEN PEPTIDE","version":"1.0","type":"link"}